Mode
Text Size
Log in / Sign up
N/A Completed N=35 Randomized Prevention

PrEP Communication Intervention for Female Clients of a Needle Exchange

Source: ClinicalTrials.gov NCT03541642 ↗
Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Change in PrEP Uptake and Adherence — 0; 1; 2; 3 Participants

Summary

This study will identify perceptions of PrEP in women who inject drugs (WWIDs) and develop and pilot test a targeted intervention that will be embedded in a large, urban syringe exchange program through an extensive formative evaluation process. Using perceptual mapping, an innovative marketing evaluation technique, WWIDs' PrEP perceptions will be incorporated into messaging in targeted counseling, materials, and text messaging to encourage PrEP adherence. This will then be tested in a pilot Randomized Controlled Trial (RCT) by comparing it to a general PrEP intervention to assess for uptake and adherence to PrEP, as well as improved self-efficacy and lower decisional conflict.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in PrEP Uptake and Adherence
0; 1; 2; 3; 1; 0
PRIMARY
PrEP Adherence Within Past Week
1; 0; 0; 0; 0; 0
PRIMARY
PrEP Adherence Appraisal
0; 3; 1; 0; 2; 0
SECONDARY
Coping Self-Efficacy
122; 101; 130; 84
SECONDARY
Decisional Conflict
5.00; 4.64; 5.00; 4.85
SECONDARY
PrEP Benefits
9.00; 9.67; 9.00; 8.67; 2.00; 8.67
SECONDARY
PrEP Barriers
0.00; 0.00; 0.00; 0.00; 0.00; 2.00
SECONDARY
PrEP Beliefs
0.00; 0.67; 10.0; 0.00; 10.0; 0.00

Eligibility Criteria

Inclusion Criteria

  • self-identifying women -HIV-
  • 18 or older
  • self-report either sharing needles or having unprotected sex in last month
  • speak and read English
  • Is not currently PrEP
  • have cell phone that receives text messages
  • have Medicaid/Medicare or other insurance that covers PrEP

Exclusion Criteria

  • self-identifying other than female
  • HIV+
  • under 18 years old
  • Doesn't speak/read English
  • No HIV risk in last three months
  • Are on PrEP
  • Do not have a cell phone that accepts text messages
  • Do not have insurance that covers PrEP
  • mental illness that interferes with cognitive understanding or ability to provide informed consent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03541642). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search